Information intended for UK healthcare professionals only.  These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. See bottom of the page for full disclaimer.

View ELIQUIS (apixaban) prescribing and adverse event reporting information

In these videos Dr Edward Middleton  (Consultant in Acute Medicine, Hull Royal Infirmary) and Dr Youssef Beaini (GPSI Cardiology, GP and Honorary Senior Lecturer, University of Bradford) summarise the main messages covered in the live webinar ’Updates in best practice management of venous thromboembolism’, broadcast on 15 June 2021.

The diagnosis of venous thromboembolism in primary care

Long-term management of venous thromboembolism

Current guidelines for the management of venous thromboembolism

Updates in best practice management of venous thromboembolism: Q&A session

These videos are best viewed in full screen mode.

The diagnosis of venous thromboembolism in primary care

Long-term management of venous thromboembolism

Current guidelines for the management of venous thromboembolism

Updates in best practice management of venous thromboembolism: Q&A session

Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK)

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines.  Bristol Myers Squibb has reviewed the scope of the videos, chosen and commissioned the speakers, and approved all materials related to the videos. Bristol Myers Squibb has paid the speakers honoraria. The views and opinions of the speakers are not necessarily those of Guidelines, its publisher, advisers, or advertisers. No part of these videos may be reproduced in any form without the permission of the publisher.

432-GB-2100782

Date of preparation: September 2021